Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Consensus Rating of “Hold” by Analysts

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has been assigned a consensus recommendation of “Hold” from the eleven brokerages that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $21.80.

Several equities analysts have recently issued reports on the company. Scotiabank reduced their target price on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a report on Thursday. Truist Financial upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Wells Fargo & Company upped their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a report on Monday, June 1st. UBS Group set a $19.00 target price on Sabra Healthcare REIT in a report on Thursday. Finally, Cantor Fitzgerald upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several institutional investors have recently modified their holdings of SBRA. Principal Financial Group Inc. grew its holdings in Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after purchasing an additional 4,431,897 shares during the period. Lasalle Investment Management Securities LLC bought a new position in Sabra Healthcare REIT during the fourth quarter valued at $66,938,000. Norges Bank bought a new position in Sabra Healthcare REIT during the fourth quarter valued at $57,945,000. Sumitomo Mitsui Trust Group Inc. grew its holdings in Sabra Healthcare REIT by 1,019.8% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after purchasing an additional 2,736,993 shares during the period. Finally, Balyasny Asset Management L.P. bought a new position in Sabra Healthcare REIT during the second quarter valued at $49,955,000. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock opened at $18.12 on Wednesday. The company has a market cap of $4.57 billion, a PE ratio of 28.76, a price-to-earnings-growth ratio of 1.35 and a beta of 0.65. Sabra Healthcare REIT has a 52 week low of $17.17 and a 52 week high of $21.28. The business has a 50 day moving average price of $19.90 and a 200-day moving average price of $19.65. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. The firm had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts anticipate that Sabra Healthcare REIT will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.6%. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.